Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$107.51
+0.6%
$113.64
$89.67
$121.64
$186.55B0.745.66 million shs3.58 million shs
Novartis AG stock logo
NVS
Novartis
$97.44
-1.6%
$97.87
$92.19
$108.78
$202.48B0.541.83 million shs1.56 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.38
+0.5%
$26.96
$25.20
$40.37
$143.04B0.6134.12 million shs46.48 million shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$573.60
+0.3%
$573.60
$415.60
$603.82
$218.24B0.81.32 million shs1.44 million shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+0.58%+0.21%-5.25%-4.02%-1.14%
Novartis AG stock logo
NVS
Novartis
-1.64%+3.25%+1.63%-9.07%-4.97%
Pfizer Inc. stock logo
PFE
Pfizer
+0.48%-2.35%-8.61%-7.61%-34.30%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
+0.26%+5.29%-1.00%+4.80%+7.59%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.996 of 5 stars
3.35.04.24.53.12.52.5
Novartis AG stock logo
NVS
Novartis
3.217 of 5 stars
2.05.02.50.03.00.02.5
Pfizer Inc. stock logo
PFE
Pfizer
4.9751 of 5 stars
3.23.04.24.83.11.73.1
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
4.7032 of 5 stars
2.43.02.54.13.22.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.67
Moderate Buy$121.5013.01% Upside
Novartis AG stock logo
NVS
Novartis
2.00
Hold$115.0018.02% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.38
Hold$36.3343.16% Upside
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
2.71
Moderate Buy$606.765.78% Upside

Current Analyst Ratings

Latest TMO, PFE, ABT, and NVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$590.00 ➝ $615.00
4/25/2024
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$600.00 ➝ $610.00
4/25/2024
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$600.00 ➝ $650.00
4/25/2024
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$621.00 ➝ $620.00
4/24/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$124.00
4/24/2024
Novartis AG stock logo
NVS
Novartis
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$114.00 ➝ $116.00
4/22/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$141.00 ➝ $140.00
4/18/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$128.00 ➝ $125.00
4/17/2024
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$630.00 ➝ $660.00
4/15/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
4/10/2024
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$550.00 ➝ $640.00
(Data available from 4/27/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$40.11B4.65$6.40 per share16.80$22.36 per share4.81
Novartis AG stock logo
NVS
Novartis
$45.44B4.38$10.94 per share8.91$19.45 per share5.01
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.46$2.99 per share8.49$15.81 per share1.61
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$42.86B5.11$30.56 per share18.77$119.21 per share4.81

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$5.72B$3.2133.4921.002.5713.96%20.32%10.59%7/18/2024 (Estimated)
Novartis AG stock logo
NVS
Novartis
$14.85B$7.4113.1512.091.5931.33%32.15%13.59%7/16/2024 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B$0.3670.509.161.143.62%10.88%4.91%5/1/2024 (Confirmed)
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.00B$15.5936.7923.842.4114.20%18.45%8.65%7/24/2024 (Estimated)

Latest TMO, PFE, ABT, and NVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/A-$0.57N/AN/AN/A  
4/24/2024Q1 2024
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$4.70$5.11+$0.41$6.76$10.14 billion$10.35 billion    
4/17/2024Q1 24
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$0.96$0.98+$0.02$1.26$9.88 billion$9.96 billion    
1/31/202412/31/2023
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$5.64$5.67+$0.03$7.14$10.73 billion$10.89 billion    
1/30/202412/31/2023
Novartis AG stock logo
NVS
Novartis
$1.64$1.53-$0.11-$1.08$11.69 billion$11.42 billion    
1/30/202412/31/2023
Pfizer Inc. stock logo
PFE
Pfizer
-$0.19$0.10+$0.29$0.80$14.37 billion$14.25 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.202.05%+12.31%68.54%53 Years
Novartis AG stock logo
NVS
Novartis
$2.432.49%+4.26%32.79%4 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.62%+2.57%466.67%15 Years
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$1.560.27%+16.74%10.01%7 Years

Latest TMO, PFE, ABT, and NVS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2024
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.426.4%5/9/20245/10/20246/14/2024
2/16/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.551.9%4/12/20244/15/20245/15/2024
2/21/2024
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.390.28%3/14/20243/15/20244/15/2024
3/1/2024
Novartis AG stock logo
NVS
Novartis
annual$3.77723.1%3/7/20243/8/20243/7/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.35
1.64
1.16
Novartis AG stock logo
NVS
Novartis
0.43
0.90
0.93
Pfizer Inc. stock logo
PFE
Pfizer
0.69
0.91
0.69
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.68
1.70
1.39

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Novartis AG stock logo
NVS
Novartis
13.12%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
89.23%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
1.10%
Novartis AG stock logo
NVS
Novartis
0.01%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.32%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.72 billionOptionable
Novartis AG stock logo
NVS
Novartis
76,0572.04 billion2.04 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.66 billion5.66 billionOptionable
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
122,000381.71 million380.49 millionOptionable

TMO, PFE, ABT, and NVS Headlines

SourceHeadline
Thermo Fisher Scientific (NYSE:TMO) Given New $650.00 Price Target at JPMorgan Chase & Co.Thermo Fisher Scientific (NYSE:TMO) Given New $650.00 Price Target at JPMorgan Chase & Co.
americanbankingnews.com - April 27 at 4:32 AM
Deutsche Bank Aktiengesellschaft Increases Thermo Fisher Scientific (NYSE:TMO) Price Target to $610.00Deutsche Bank Aktiengesellschaft Increases Thermo Fisher Scientific (NYSE:TMO) Price Target to $610.00
americanbankingnews.com - April 27 at 4:32 AM
Thermo Fisher Scientific (NYSE:TMO) PT Raised to $615.00Thermo Fisher Scientific (NYSE:TMO) PT Raised to $615.00
americanbankingnews.com - April 27 at 4:32 AM
Thermo Fisher Scientific (NYSE:TMO) Price Target Cut to $620.00 by Analysts at Robert W. BairdThermo Fisher Scientific (NYSE:TMO) Price Target Cut to $620.00 by Analysts at Robert W. Baird
americanbankingnews.com - April 27 at 3:48 AM
Thermo Fisher Scientific Inc. (NYSE:TMO) Receives Average Rating of "Moderate Buy" from AnalystsThermo Fisher Scientific Inc. (NYSE:TMO) Receives Average Rating of "Moderate Buy" from Analysts
americanbankingnews.com - April 27 at 2:38 AM
Research Analysts Set Expectations for Thermo Fisher Scientific Inc.s Q2 2024 Earnings (NYSE:TMO)Research Analysts Set Expectations for Thermo Fisher Scientific Inc.'s Q2 2024 Earnings (NYSE:TMO)
americanbankingnews.com - April 27 at 2:00 AM
Markel Group Inc. Raises Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)Markel Group Inc. Raises Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)
marketbeat.com - April 27 at 12:59 AM
These Analysts Revise Their Forecasts On Thermo Fisher Scientific Following Upbeat EarningsThese Analysts Revise Their Forecasts On Thermo Fisher Scientific Following Upbeat Earnings
msn.com - April 26 at 7:43 PM
Thermo Fisher Scientific Inc. (TMO) Q1 2024 Earnings Call TranscriptThermo Fisher Scientific Inc. (TMO) Q1 2024 Earnings Call Transcript
seekingalpha.com - April 26 at 9:41 AM
Thermo Fisher Outperforms in Q1 with Strong Revenue and Earnings Growth, Justifying Buy RatingThermo Fisher Outperforms in Q1 with Strong Revenue and Earnings Growth, Justifying Buy Rating
markets.businessinsider.com - April 26 at 9:41 AM
Thermo Fisher Scientific Inc. (NYSE:TMO) to Post Q2 2024 Earnings of $5.19 Per Share, Leerink Partnrs ForecastsThermo Fisher Scientific Inc. (NYSE:TMO) to Post Q2 2024 Earnings of $5.19 Per Share, Leerink Partnrs Forecasts
marketbeat.com - April 26 at 7:52 AM
Bank Julius Baer & Co. Ltd Zurich Cuts Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)Bank Julius Baer & Co. Ltd Zurich Cuts Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)
marketbeat.com - April 25 at 8:21 PM
Thermo Fisher Scientific Reports Better Than Expected Q1 ResultsThermo Fisher Scientific Reports Better Than Expected Q1 Results
cweb.com - April 25 at 1:38 PM
Company News for Apr 25, 2024Company News for Apr 25, 2024
finance.yahoo.com - April 25 at 1:38 PM
Thermo Fisher Scientific Inc. (NYSE:TMO) Q1 2024 Earnings Call TranscriptThermo Fisher Scientific Inc. (NYSE:TMO) Q1 2024 Earnings Call Transcript
finance.yahoo.com - April 25 at 1:38 PM
7 Analysts Assess Thermo Fisher Scientific: What You Need To Know7 Analysts Assess Thermo Fisher Scientific: What You Need To Know
markets.businessinsider.com - April 25 at 8:38 AM
Thermo Fisher Scientific Inc (TMO) Q1 2024 Earnings Call Transcript Highlights: Robust ...Thermo Fisher Scientific Inc (TMO) Q1 2024 Earnings Call Transcript Highlights: Robust ...
finance.yahoo.com - April 25 at 8:38 AM
Thermo Fisher Scientific First Quarter 2024 Earnings: Beats ExpectationsThermo Fisher Scientific First Quarter 2024 Earnings: Beats Expectations
finance.yahoo.com - April 25 at 8:38 AM
Thermo Fisher Scientific (NYSE:TMO) Price Target Cut to $620.00Thermo Fisher Scientific (NYSE:TMO) Price Target Cut to $620.00
marketbeat.com - April 25 at 8:10 AM
Thermo Fisher Scientific (NYSE:TMO) Shares Gap Up to $548.38Thermo Fisher Scientific (NYSE:TMO) Shares Gap Up to $548.38
americanbankingnews.com - April 25 at 5:50 AM
Q1 2024 Thermo Fisher Scientific Inc Earnings CallQ1 2024 Thermo Fisher Scientific Inc Earnings Call
finance.yahoo.com - April 25 at 2:11 AM
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by Lyell Wealth Management LPThermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by Lyell Wealth Management LP
marketbeat.com - April 25 at 12:42 AM
Thermo Fisher Scientific (TMO) Q1 2024 Earnings Call TranscriptThermo Fisher Scientific (TMO) Q1 2024 Earnings Call Transcript
fool.com - April 24 at 4:05 PM
Thermo Fisher (TMO) Q1 Earnings Top Estimates, 2024 View UpThermo Fisher (TMO) Q1 Earnings Top Estimates, 2024 View Up
zacks.com - April 24 at 3:15 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Abbott Laboratories logo

Abbott Laboratories

NYSE:ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Novartis logo

Novartis

NYSE:NVS
Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Thermo Fisher Scientific logo

Thermo Fisher Scientific

NYSE:TMO
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.